COX-2 Inhibitors and Gastric Cancer
The evidence that cyclooxygenase-2 (COX-2) is upregulated and plays an important role in carcinogenesis of gastric cancer has triggered the topic of COX-2 inhibitors as chemopreventive agents for gastric cancer. Studies find that COX-2 inhibitors are associated not only with chemoprophylactic effect...
Saved in:
Main Authors: | Zhen Wang, Jun-qiang Chen, Jin-lu Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2014-01-01
|
Series: | Gastroenterology Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2014/132320 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Seizure following the Use of the COX-2 Inhibitor Etoricoxib
by: Valentina Arnao, et al.
Published: (2017-01-01) -
Multivariate Cox regression analysis of prognostic genes and therapeutic mechanisms of gastric cancer
by: Yangyang Xiao, et al.
Published: (2025-02-01) -
Do NSAID/COX-2 Inhibitors Increase Nonunion After Fracture Surgery? Dilemma and Consideration In Use
by: Azmi
Published: (2022-10-01) -
Synthesis, Biological Activity, and Molecular Modeling Studies of Pyrazole and Triazole Derivatives as Selective COX-2 Inhibitors
by: Mohyeddin Assali, et al.
Published: (2020-01-01) -
Analysis of Gene Expression in Human Dermal Fibroblasts Treated with Senescence-Modulating COX Inhibitors
by: Jeong A. Han, et al.
Published: (2017-06-01)